September 29, 2024

IMS 2024 Myeloma Oral Sessions Day 4

The final day of presentations at the International Myeloma Society (IMS) meeting in Brazil provided updates on the use of various treatments for patients with relapsed and refractory multiple myeloma. Let us break down the key findings for you… Antibody Drug Conjugate Therapy Blenrep (belanatamab mafodotin) Results of a large trial of Blenrep (belanatamab mafodotin), […]

September 28, 2024

IMS 2024 Myeloma Oral Sessions Day 3

The third day of presentations at the International Myeloma Society (IMS) meeting in Brazil offered a glimpse into the potential of new treatment strategies for patients with relapsed/refractory multiple myeloma (RRMM) and provided additional updates on quadruplet regiments for newly diagnosed multiple myeloma (NDMM). Talvey-Based Combinations for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Talvey (talquetamab), […]

September 28, 2024

Structural basis for the rescue of hyperexcitable cells by the amyotrophic lateral sclerosis drug Riluzole – Nature.com

September 28, 2024

Evaluation of disease activity in systemic lupus erythematosus using standard deviation of lymphocyte volume combined with red blood cell count and lymphocyte percentage – Nature.com

September 28, 2024

Ipswich legend Marcus Stewart on Motor Neurone Disease: I don’t live with it – it lives with me – Sky Sports